Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: The CDKN2A (p16INK4a and p14ARF) and p53 genes are major targets for inactivation

Carcinogenesis

Volumn 23, Issue 4, 2002, Pages 645-655

  Smeds, Johanna ^a   Berggren, Petra ^a   Ma, Xin ^a   Xu, Zhijian ^b   Hemminki, Kari ^a   Kumar, Rajiv ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P14; PROTEIN P16; PROTEIN P53;

5' UNTRANSLATED REGION; ADULT; AGED; ALLELE; AMINO TERMINAL SEQUENCE; ARTICLE; CANCER TISSUE; CELL CYCLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA METHYLATION; ESOPHAGUS CARCINOMA; EXON; FEMALE; FISHER EXACT TEST; GENE DELETION; GENE INACTIVATION; GENE LOCUS; GENE MUTATION; GENE TARGETING; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SCREENING; GERM LINE; HEMIZYGOSITY; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; HUMAN GENOME; HUMAN TISSUE; MALE; MOLECULAR PHYLOGENY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; WILD TYPE;

EID: 0036257349     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/23.4.645     Document Type: Article

References (58)

1. Nutrition and esophageal cancer
2. Genetic steps in the development of squamous cell carcinoma of the esophagus
3. Genetic progression and heterogeneity associated with the development of esophageal squamous cell carcinoma
4. Identification of novel regions of allelic loss from a genomewide scan of esophageal squamous-cell carcinoma in a high-risk Chinese population
5. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China
6. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran
7. TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe
8. IARC p53 mutation database: A relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer
9. Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinomas from northern Iran
10. Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas
11. Mechanisms of inactivation of p14ARF, p15INK4b and p16INK4a genes in human esophageal squamous cell carcinoma
12. p53 and p16/CDKN2 gene mutations in esophageal tumors from a high-incidence area in South Africa
13. Selective deletion of exon 1beta of the p19ARF gene in metastatic melanoma cell lines
14. p16 (MTS-1/CDKN2/INK4a) in cancer progression
15. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families
16. Role of p53 gene mutations in human esophageal carcinogenesis: Results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions
17. Early deregulation of the the p16ink4a-cyclin D1/cyclin-dependent kinase 4-retinoblastoma pathway in cell proliferation-driven esophageal tumorigenesis in zinc-deficient rats
18. Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer
19. Tumor surveillance via the ARF-p53 pathway
20. The Pezcoller lecture: Cancer cell cycles revisited
21. Xiong Control of p53 ubiquitination and nuclear export by MDM2 and ARF
22. p53, the cellular gatekeeper for growth and division
23. Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma
24. Obligate roles for p16 (Ink4a) and p19 (Arf)-p53 in the suppression of murine pancreatic neoplasia
25. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
26. Mutations in the CDKN2A (p16INK4a) gene in microdissected sporadic primary melanomas
27. Loss of heterozygosity at chromosome 9p21 (INK4-p14ARF locus): Homozygous deletions and mutations in the p16 and p14ARF genes in sporadic primary melanomas
28. A rapid fluorescence based multiplex polymerase chain reaction-single-strand conformation polymorphism method for p53 mutation detection
29. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism
30. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
31. Hypermethylation-associated inactivation of p14 (ARF) is independent of p16 (INK4a) methylation and p53 mutational status
32. Analysis of G(1)/S checkpoint regulators in metastatic melanoma
33. A single nucleotide polymorphism in the 3′ untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare
34. p53 intron 7 polymorphisms in urinary bladder cancer patients and controls
35. Ethnic variation in genotype frequencies of a p53 intron 7 polymorphism
36. p53 sends nucleotides to repair DNA
37. A novel polymorphism (-88 C>A) in the 5′ UTR of the p53R2 gene
38. A germline deletion of p14 (ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family
39. The p16INK4a/CDKN2A tumor suppressor and its relatives
40. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
41. Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma
42. Mutations associated with familial melanoma impair p16INK4 function
43. Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations
44. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer
45. p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2
46. Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF
47. Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization
48. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
49. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer
50. Human ARF binds E2F1 and inhibits its transcriptional activity
51. p16 (INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer
52. Research on esophageal cancer in China: A review
53. Gain of function mutations in the tumor suppressor gene p53
54. Oncogenic mutations of the p53 tumor suppressor: The demons of the guardian of the genome
55. Retention of wild-type p53 in tumors from p53 heterozygous mice: Reduction of p53 dosage can promote cancer formation
56. Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells
57. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
58. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis